DNDi welcomes the ongoing discussions on Global Health Architecture reform and emphasizes that product development and equitable access must be treated as core functions, that are addressed coherently across all workstreams.
Market forces alone will not deliver the innovation or access needed to meet public health priorities. Global health reform discussions must address how innovation systems are designed, governed, and financed to serve public health and equity objectives. This includes ensuring sustainable financing for needs-driven R&D, embedding access conditions in public investments, strengthening regional research and manufacturing capacity, and supporting technology transfer and data sharing.
DNDi also stresses the importance of recognizing and strengthening proven public-interest R&D models, including Product Development Partnerships, that have already delivered innovation where market incentives are weak or absent, while supporting long-term partnerships and research capacity in partner countries.